U.S. Stem Cell, Inc. (USRM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 9, 2026

U.S. Stem Cell Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
0.010.040.02-1.36
Cash & Short-Term Investments
0.010.040.02-1.36
Cash Growth
-86.97%112.13%--37.53%
Receivables
000.050.050.02
Inventory
000.010.010.09
Prepaid Expenses
0.060.010.010.010.04
Total Current Assets
0.070.050.090.071.51
Property, Plant & Equipment
----0.24
Long-Term Investments
---0.020.06
Other Long-Term Assets
----0.01
Total Assets
0.070.050.090.091.82
Accounts Payable
1.621.371.281.191.18
Accrued Expenses
2.581.951.511.121.16
Short-Term Debt
5.424.293.633.272.23
Current Portion of Long-Term Debt
3.983.963.962.670.24
Current Portion of Leases
----0.23
Current Unearned Revenue
0.470.470.470.510.89
Total Current Liabilities
14.0812.0410.858.755.92
Long-Term Debt
0.680.720.760.762.56
Long-Term Leases
----0.04
Long-Term Unearned Revenue
0.050.060.060.060.19
Total Liabilities
14.8112.8211.679.578.7
Common Stock
0.630.50.440.420.38
Additional Paid-In Capital
127.14126.53124.5123.73122.53
Retained Earnings
-142.52-139.8-136.51-133.62-129.79
Total Common Equity
-14.75-12.77-11.58-9.48-6.88
Shareholders' Equity
-14.75-12.77-11.58-9.48-6.88
Total Liabilities & Equity
0.070.050.090.091.82
Total Debt
10.088.978.356.695.29
Net Cash (Debt)
-10.08-8.93-8.33-6.69-3.93
Net Cash Per Share
-0.02-0.02-0.02-0.02-0.01
Filing Date Shares Outstanding
641.51571.63452.41417.72386.68
Total Common Shares Outstanding
634.4503.53435.56417.72378.08
Working Capital
-14.01-11.99-10.76-8.68-4.41
Book Value Per Share
-0.02-0.03-0.03-0.02-0.02
Tangible Book Value
-14.75-12.77-11.58-9.48-6.88
Tangible Book Value Per Share
-0.02-0.03-0.03-0.02-0.02
Machinery
---0.010.18
Leasehold Improvements
----0.36
Updated Apr 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.